Human Phenotype Ontology 
Grandparent Node:
expand
Neuroectodermal neoplasm (HP:0030061)help
Parent Node:
expand
Abnormal glial cell morphology (HP:0100705)help
Parent Node:
expand
Malignant neoplasm of the central nervous system (HP:0100836)help
Parent Node:
expand
Neuroepithelial neoplasm (HP:0030063)help
..Starting node
..expand
Glioma (HP:0009733)help
Term ID: 9733
Name: Glioma
Synonym:
Definition: The presence of a glioma, which is a neoplasm of the central nervous system originating from a glial cell (astrocytes or oligodendrocytes).
Comments:
Reference: HP:0009733
Genes and Diseases:
 
       Child Nodes:
........expandEpendymoma (HP:0002888) help
........expandAstrocytoma (HP:0009592) help
................... HP:0009718 Subependymal giant-cell astrocytoma
........expandOptic nerve glioma (HP:0009734) help
........expandCerebellar glioma (HP:0010795) help
........expandBrainstem glioma (HP:0010796) help
........expandGlioblastoma multiforme (HP:0012174) help

 Sister Nodes: 
..expandNeurocytoma (HP:0030064) help
..expandPinealoma (HP:0010799) help
..expandPrimitive neuroectodermal tumor (HP:0030065) help
..expandRetinoblastoma (HP:0009919) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0009733HP:0009733Glioma0APC CL E G H324583OMIM:175100Adenomatous polyposis coli3179
HP:0009733HP:0009733Glioma0APC CL E G H324583ORPHA:247806APC-related attenuated familial adenomatous polyposis3179
HP:0009733HP:0009733Glioma0APC CL E G H324583ORPHA:79665Gardner syndrome3179
HP:0009733HP:0009733Glioma0APC CL E G H324583ORPHA:99818Turcot syndrome with polyposisHP:0040284 - Very rare3179
HP:0009733HP:0009733Glioma0APC2 CL E G H1029724036ORPHA:821Sotos syndrome1
HP:0009733HP:0009733Glioma0BMPR1A CL E G H6571076ORPHA:440437Familial colorectal cancer Type X385
HP:0009733HP:0009733Glioma0BRCA2 CL E G H6751101OMIM:613029Glioma susceptibility 37642
HP:0009733HP:0009733Glioma0CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 12
HP:0009733HP:0009733Glioma0CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1102
HP:0009733HP:0009733Glioma0CDKN2A CL E G H10291787ORPHA:524Li-Fraumeni syndrome289
HP:0009733HP:0009733Glioma0CDKN2A CL E G H10291787OMIM:155755Melanoma-Astrocytoma syndrome289
HP:0009733HP:0009733Glioma0CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 11
HP:0009733HP:0009733Glioma0CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1
HP:0009733HP:0009733Glioma0CHEK2 CL E G H1120016627ORPHA:524Li-Fraumeni syndrome833
HP:0009733HP:0009733Glioma0CHEK2 CL E G H1120016627OMIM:609265LI-FRAUMENI SYNDROME 2; LFS2833
HP:0009733HP:0009733Glioma0EPCAM CL E G H407211529ORPHA:144Lynch syndrome170
HP:0009733HP:0009733Glioma0ERBB2 CL E G H20643430OMIM:137800Glioma susceptibility 177
HP:0009733HP:0009733Glioma0FAN1 CL E G H2290929170ORPHA:144Lynch syndrome15
HP:0009733HP:0009733Glioma0IDH1 CL E G H34175382OMIM:137800Glioma susceptibility 115
HP:0009733HP:0009733Glioma0IDH1 CL E G H34175382ORPHA:163634Maffucci syndrome15
HP:0009733HP:0009733Glioma0IDH2 CL E G H34185383ORPHA:163634Maffucci syndrome29
HP:0009733HP:0009733Glioma0IFNG CL E G H34585438ORPHA:805Tuberous sclerosis complex23
HP:0009733HP:0009733Glioma0IFNG CL E G H34585438OMIM:613254Tuberous sclerosis-223
HP:0009733HP:0009733Glioma0KRAS CL E G H38456407ORPHA:144Lynch syndrome196
HP:0009733HP:0009733Glioma0LRP5 CL E G H40416697OMIM:259770Osteoporosis-Pseudoglioma syndrome.125
HP:0009733HP:0009733Glioma0MDM2 CL E G H41936973ORPHA:524Li-Fraumeni syndrome1
HP:0009733HP:0009733Glioma0MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1462
HP:0009733HP:0009733Glioma0MLH1 CL E G H42927127ORPHA:144Lynch syndrome1819
HP:0009733HP:0009733Glioma0MLH1 CL E G H42927127OMIM:276300Mismatch repair cancer syndrome 11819
HP:0009733HP:0009733Glioma0MLH3 CL E G H270307128ORPHA:144Lynch syndrome131
HP:0009733HP:0009733Glioma0MSH2 CL E G H44367325ORPHA:144Lynch syndrome2162
HP:0009733HP:0009733Glioma0MSH2 CL E G H44367325OMIM:619096MISMATCH REPAIR CANCER SYNDROME 2; MMRCS22162
HP:0009733HP:0009733Glioma0MSH3 CL E G H44377326OMIM:617100Familial adenomatous polyposis 45
HP:0009733HP:0009733Glioma0MSH3 CL E G H44377326ORPHA:480536MSH3-related attenuated familial adenomatous polyposis5
HP:0009733HP:0009733Glioma0MSH6 CL E G H29567329ORPHA:144Lynch syndrome2232
HP:0009733HP:0009733Glioma0MSH6 CL E G H29567329OMIM:619097MISMATCH REPAIR CANCER SYNDROME 3; MMRCS32232
HP:0009733HP:0009733Glioma0NBN CL E G H46837652OMIM:251260Nijmegen breakage syndrome.706
HP:0009733HP:0009733Glioma0NBN CL E G H46837652ORPHA:647Nijmegen breakage syndromeHP:0040283 - Occasional706
HP:0009733HP:0009733Glioma0NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndromeHP:0040283 - Occasional1952
HP:0009733HP:0009733Glioma0NF1 CL E G H47637765ORPHA:363700Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion1952
HP:0009733HP:0009733Glioma0NF1 CL E G H47637765OMIM:162200Neurofibromatosis, type I1952
HP:0009733HP:0009733Glioma0NF1 CL E G H47637765OMIM:601321Neurofibromatosis-Noonan syndrome1952
HP:0009733HP:0009733Glioma0NF2 CL E G H47717773ORPHA:637Neurofibromatosis type 2HP:0040284 - Very rare220
HP:0009733HP:0009733Glioma0NF2 CL E G H47717773OMIM:101000Neurofibromatosis, type II220
HP:0009733HP:0009733Glioma0NSD1 CL E G H6432414234ORPHA:821Sotos syndrome544
HP:0009733HP:0009733Glioma0PIK3CA CL E G H52908975ORPHA:144Lynch syndrome162
HP:0009733HP:0009733Glioma0PMS1 CL E G H53789121ORPHA:144Lynch syndrome56
HP:0009733HP:0009733Glioma0PMS2 CL E G H53959122ORPHA:144Lynch syndrome1121
HP:0009733HP:0009733Glioma0PMS2 CL E G H53959122OMIM:619101MISMATCH REPAIR CANCER SYNDROME 4; MMRCS41121
HP:0009733HP:0009733Glioma0POT1 CL E G H2591317284OMIM:616568Glioma susceptibility 9.23
HP:0009733HP:0009733Glioma0RELA CL E G H59709955ORPHA:251636Ependymoma1
HP:0009733HP:0009733Glioma0RPS20 CL E G H622410405ORPHA:440437Familial colorectal cancer Type X1
HP:0009733HP:0009733Glioma0SEMA4A CL E G H6421810729ORPHA:440437Familial colorectal cancer Type X48
HP:0009733HP:0009733Glioma0SETBP1 CL E G H2604015573ORPHA:798Schinzel-Giedion syndrome143
HP:0009733HP:0009733Glioma0SETD2 CL E G H2907218420ORPHA:821Sotos syndrome60
HP:0009733HP:0009733Glioma0SMO CL E G H660811119OMIM:241800Hypothalamic hamartomascongenital hypothalamic hamartoma syndrome, included.22
HP:0009733HP:0009733Glioma0TGFBR2 CL E G H704811773ORPHA:144Lynch syndrome253
HP:0009733HP:0009733Glioma0TP53 CL E G H715711998OMIM:137800Glioma susceptibility 1911
HP:0009733HP:0009733Glioma0TP53 CL E G H715711998ORPHA:524Li-Fraumeni syndrome911
HP:0009733HP:0009733Glioma0TSC1 CL E G H724812362ORPHA:805Tuberous sclerosis complex1090
HP:0009733HP:0009733Glioma0TSC1 CL E G H724812362OMIM:191100Tuberous sclerosis-11090
HP:0009733HP:0009733Glioma0TSC2 CL E G H724912363ORPHA:805Tuberous sclerosis complex2738
HP:0009733HP:0009733Glioma0TSC2 CL E G H724912363OMIM:613254Tuberous sclerosis-22738
HP:0009733HP:0009733Glioma0ZFTA CL E G H6599828449ORPHA:251636Ependymoma
HP:0009733HP:0009592Astrocytoma1APC CL E G H324583OMIM:175100Adenomatous polyposis coli.3179
HP:0009733HP:0009592Astrocytoma1APC CL E G H324583ORPHA:247806APC-related attenuated familial adenomatous polyposisHP:0040284 - Very rare3179
HP:0009733HP:0009592Astrocytoma1APC CL E G H324583ORPHA:79665Gardner syndromeHP:0040284 - Very rare3179
HP:0009733HP:0009592Astrocytoma1APC CL E G H324583ORPHA:99818Turcot syndrome with polyposisHP:0040284 - Very rare3179
HP:0009733HP:0002888Ependymoma1APC CL E G H324583ORPHA:99818Turcot syndrome with polyposisHP:0040284 - Very rare3179
HP:0009733HP:0012174Glioblastoma multiforme1APC CL E G H324583ORPHA:99818Turcot syndrome with polyposisHP:0040284 - Very rare3179
HP:0009733HP:0009592Astrocytoma1APC2 CL E G H1029724036ORPHA:821Sotos syndromeHP:0040284 - Very rare1
HP:0009733HP:0012174Glioblastoma multiforme1BMPR1A CL E G H6571076ORPHA:440437Familial colorectal cancer Type XHP:0040281 - Very frequent385
HP:0009733HP:0009592Astrocytoma1BRCA2 CL E G H6751101OMIM:613029Glioma susceptibility 3.7642
HP:0009733HP:0012174Glioblastoma multiforme1BRCA2 CL E G H6751101OMIM:613029Glioma susceptibility 3.7642
HP:0009733HP:0002888Ependymoma1CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 1HP:0040284 - Very rare2
HP:0009733HP:0002888Ependymoma1CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1HP:0040284 - Very rare102
HP:0009733HP:0002888Ependymoma1CDKN2A CL E G H10291787ORPHA:524Li-Fraumeni syndromeHP:0040283 - Occasional289
HP:0009733HP:0009592Astrocytoma1CDKN2A CL E G H10291787ORPHA:524Li-Fraumeni syndromeHP:0040283 - Occasional289
HP:0009733HP:0012174Glioblastoma multiforme1CDKN2A CL E G H10291787ORPHA:524Li-Fraumeni syndromeHP:0040283 - Occasional289
HP:0009733HP:0009592Astrocytoma1CDKN2A CL E G H10291787OMIM:155755Melanoma-Astrocytoma syndrome.289
HP:0009733HP:0002888Ependymoma1CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 1HP:0040284 - Very rare1
HP:0009733HP:0002888Ependymoma1CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1HP:0040284 - Very rare
HP:0009733HP:0009592Astrocytoma1CHEK2 CL E G H1120016627ORPHA:524Li-Fraumeni syndromeHP:0040283 - Occasional833
HP:0009733HP:0012174Glioblastoma multiforme1CHEK2 CL E G H1120016627ORPHA:524Li-Fraumeni syndromeHP:0040283 - Occasional833
HP:0009733HP:0002888Ependymoma1CHEK2 CL E G H1120016627ORPHA:524Li-Fraumeni syndromeHP:0040283 - Occasional833
HP:0009733HP:0012174Glioblastoma multiforme1EPCAM CL E G H407211529ORPHA:144Lynch syndromeHP:0040281 - Very frequent170
HP:0009733HP:0012174Glioblastoma multiforme1ERBB2 CL E G H20643430OMIM:137800Glioma susceptibility 1.77
HP:0009733HP:0002888Ependymoma1ERBB2 CL E G H20643430OMIM:137800Glioma susceptibility 1.77
HP:0009733HP:0009592Astrocytoma1ERBB2 CL E G H20643430OMIM:137800Glioma susceptibility 1.77
HP:0009733HP:0012174Glioblastoma multiforme1FAN1 CL E G H2290929170ORPHA:144Lynch syndromeHP:0040281 - Very frequent15
HP:0009733HP:0002888Ependymoma1IDH1 CL E G H34175382OMIM:137800Glioma susceptibility 1.15
HP:0009733HP:0012174Glioblastoma multiforme1IDH1 CL E G H34175382OMIM:137800Glioma susceptibility 1.15
HP:0009733HP:0009592Astrocytoma1IDH1 CL E G H34175382OMIM:137800Glioma susceptibility 1.15
HP:0009733HP:0009592Astrocytoma1IDH1 CL E G H34175382ORPHA:163634Maffucci syndromeHP:0040283 - Occasional15
HP:0009733HP:0009592Astrocytoma1IDH2 CL E G H34185383ORPHA:163634Maffucci syndromeHP:0040283 - Occasional29
HP:0009733HP:0009592Astrocytoma1IFNG CL E G H34585438ORPHA:805Tuberous sclerosis complex23
HP:0009733HP:0009592Astrocytoma1IFNG CL E G H34585438OMIM:613254Tuberous sclerosis-2.23
HP:0009733HP:0002888Ependymoma1IFNG CL E G H34585438OMIM:613254Tuberous sclerosis-2.23
HP:0009733HP:0009734Optic nerve glioma1IFNG CL E G H34585438OMIM:613254Tuberous sclerosis-2.23
HP:0009733HP:0012174Glioblastoma multiforme1KRAS CL E G H38456407ORPHA:144Lynch syndromeHP:0040281 - Very frequent196
HP:0009733HP:0002888Ependymoma1MDM2 CL E G H41936973ORPHA:524Li-Fraumeni syndromeHP:0040283 - Occasional1
HP:0009733HP:0009592Astrocytoma1MDM2 CL E G H41936973ORPHA:524Li-Fraumeni syndromeHP:0040283 - Occasional1
HP:0009733HP:0012174Glioblastoma multiforme1MDM2 CL E G H41936973ORPHA:524Li-Fraumeni syndromeHP:0040283 - Occasional1
HP:0009733HP:0002888Ependymoma1MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1HP:0040284 - Very rare462
HP:0009733HP:0012174Glioblastoma multiforme1MLH1 CL E G H42927127ORPHA:144Lynch syndromeHP:0040281 - Very frequent1819
HP:0009733HP:0009592Astrocytoma1MLH1 CL E G H42927127OMIM:276300Mismatch repair cancer syndrome 11819
HP:0009733HP:0002888Ependymoma1MLH1 CL E G H42927127OMIM:276300Mismatch repair cancer syndrome 1.1819
HP:0009733HP:0033681Oligodendroglioma1MLH1 CL E G H42927127OMIM:276300Mismatch repair cancer syndrome 11819
HP:0009733HP:0012174Glioblastoma multiforme1MLH1 CL E G H42927127OMIM:276300Mismatch repair cancer syndrome 11819
HP:0009733HP:0012174Glioblastoma multiforme1MLH3 CL E G H270307128ORPHA:144Lynch syndromeHP:0040281 - Very frequent131
HP:0009733HP:0012174Glioblastoma multiforme1MSH2 CL E G H44367325ORPHA:144Lynch syndromeHP:0040281 - Very frequent2162
HP:0009733HP:0012174Glioblastoma multiforme1MSH2 CL E G H44367325OMIM:619096MISMATCH REPAIR CANCER SYNDROME 2; MMRCS22162
HP:0009733HP:0009592Astrocytoma1MSH3 CL E G H44377326OMIM:617100Familial adenomatous polyposis 4.5
HP:0009733HP:0009592Astrocytoma1MSH3 CL E G H44377326ORPHA:480536MSH3-related attenuated familial adenomatous polyposisHP:0040282 - Frequent5
HP:0009733HP:0012174Glioblastoma multiforme1MSH6 CL E G H29567329ORPHA:144Lynch syndromeHP:0040281 - Very frequent2232
HP:0009733HP:0012174Glioblastoma multiforme1MSH6 CL E G H29567329OMIM:619097MISMATCH REPAIR CANCER SYNDROME 3; MMRCS32232
HP:0009733HP:0009592Astrocytoma1MSH6 CL E G H29567329OMIM:619097MISMATCH REPAIR CANCER SYNDROME 3; MMRCS32232
HP:0009733HP:0010796Brainstem glioma1NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndromeHP:0040283 - Occasional1952
HP:0009733HP:0009734Optic nerve glioma1NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndromeHP:0040283 - Occasional1952
HP:0009733HP:0010795Cerebellar glioma1NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndromeHP:0040283 - Occasional1952
HP:0009733HP:0009734Optic nerve glioma1NF1 CL E G H47637765ORPHA:363700Neurofibromatosis type 1 due to NF1 mutation or intragenic deletionHP:0040283 - Occasional1952
HP:0009733HP:0009592Astrocytoma1NF1 CL E G H47637765OMIM:162200Neurofibromatosis, type I.1952
HP:0009733HP:0009734Optic nerve glioma1NF1 CL E G H47637765OMIM:162200Neurofibromatosis, type I1952
HP:0009733HP:0009734Optic nerve glioma1NF1 CL E G H47637765OMIM:601321Neurofibromatosis-Noonan syndrome1952
HP:0009733HP:0002888Ependymoma1NF2 CL E G H47717773ORPHA:637Neurofibromatosis type 2HP:0040283 - Occasional220
HP:0009733HP:0009592Astrocytoma1NF2 CL E G H47717773ORPHA:637Neurofibromatosis type 2HP:0040284 - Very rare220
HP:0009733HP:0009592Astrocytoma1NF2 CL E G H47717773OMIM:101000Neurofibromatosis, type II.220
HP:0009733HP:0002888Ependymoma1NF2 CL E G H47717773OMIM:101000Neurofibromatosis, type II220
HP:0009733HP:0009592Astrocytoma1NSD1 CL E G H6432414234ORPHA:821Sotos syndromeHP:0040284 - Very rare544
HP:0009733HP:0012174Glioblastoma multiforme1PIK3CA CL E G H52908975ORPHA:144Lynch syndromeHP:0040281 - Very frequent162
HP:0009733HP:0012174Glioblastoma multiforme1PMS1 CL E G H53789121ORPHA:144Lynch syndromeHP:0040281 - Very frequent56
HP:0009733HP:0012174Glioblastoma multiforme1PMS2 CL E G H53959122ORPHA:144Lynch syndromeHP:0040281 - Very frequent1121
HP:0009733HP:0009592Astrocytoma1PMS2 CL E G H53959122OMIM:619101MISMATCH REPAIR CANCER SYNDROME 4; MMRCS41121
HP:0009733HP:0012174Glioblastoma multiforme1PMS2 CL E G H53959122OMIM:619101MISMATCH REPAIR CANCER SYNDROME 4; MMRCS41121
HP:0009733HP:0009592Astrocytoma1POT1 CL E G H2591317284OMIM:616568Glioma susceptibility 9.23
HP:0009733HP:0002888Ependymoma1RELA CL E G H59709955ORPHA:251636EpendymomaHP:0040280 - Obligate1
HP:0009733HP:0012174Glioblastoma multiforme1RPS20 CL E G H622410405ORPHA:440437Familial colorectal cancer Type XHP:0040281 - Very frequent1
HP:0009733HP:0012174Glioblastoma multiforme1SEMA4A CL E G H6421810729ORPHA:440437Familial colorectal cancer Type XHP:0040281 - Very frequent48
HP:0009733HP:0002888Ependymoma1SETBP1 CL E G H2604015573ORPHA:798Schinzel-Giedion syndromeHP:0040284 - Very rare143
HP:0009733HP:0009592Astrocytoma1SETD2 CL E G H2907218420ORPHA:821Sotos syndromeHP:0040284 - Very rare60
HP:0009733HP:0012174Glioblastoma multiforme1TGFBR2 CL E G H704811773ORPHA:144Lynch syndromeHP:0040281 - Very frequent253
HP:0009733HP:0002888Ependymoma1TP53 CL E G H715711998OMIM:137800Glioma susceptibility 1.911
HP:0009733HP:0012174Glioblastoma multiforme1TP53 CL E G H715711998OMIM:137800Glioma susceptibility 1.911
HP:0009733HP:0009592Astrocytoma1TP53 CL E G H715711998OMIM:137800Glioma susceptibility 1.911
HP:0009733HP:0012174Glioblastoma multiforme1TP53 CL E G H715711998ORPHA:524Li-Fraumeni syndromeHP:0040283 - Occasional911
HP:0009733HP:0009592Astrocytoma1TP53 CL E G H715711998ORPHA:524Li-Fraumeni syndromeHP:0040283 - Occasional911
HP:0009733HP:0002888Ependymoma1TP53 CL E G H715711998ORPHA:524Li-Fraumeni syndromeHP:0040283 - Occasional911
HP:0009733HP:0009592Astrocytoma1TSC1 CL E G H724812362ORPHA:805Tuberous sclerosis complex1090
HP:0009733HP:0009592Astrocytoma1TSC1 CL E G H724812362OMIM:191100Tuberous sclerosis-1.1090
HP:0009733HP:0009734Optic nerve glioma1TSC1 CL E G H724812362OMIM:191100Tuberous sclerosis-1.1090
HP:0009733HP:0002888Ependymoma1TSC1 CL E G H724812362OMIM:191100Tuberous sclerosis-1.1090
HP:0009733HP:0009592Astrocytoma1TSC2 CL E G H724912363ORPHA:805Tuberous sclerosis complex2738
HP:0009733HP:0002888Ependymoma1TSC2 CL E G H724912363OMIM:613254Tuberous sclerosis-2.2738
HP:0009733HP:0009592Astrocytoma1TSC2 CL E G H724912363OMIM:613254Tuberous sclerosis-2.2738
HP:0009733HP:0009734Optic nerve glioma1TSC2 CL E G H724912363OMIM:613254Tuberous sclerosis-2.2738
HP:0009733HP:0002888Ependymoma1ZFTA CL E G H6599828449ORPHA:251636EpendymomaHP:0040280 - Obligate
HP:0009733HP:0033680Pilocytic astrocytoma2 CL E G H
HP:0009733HP:0009718Subependymal giant-cell astrocytoma2IFNG CL E G H34585438ORPHA:805Tuberous sclerosis complexHP:0040283 - Occasional23
HP:0009733HP:0009718Subependymal giant-cell astrocytoma2IFNG CL E G H34585438OMIM:613254Tuberous sclerosis-223
HP:0009733HP:0033682Pleomorphic xanthoastrocytoma2MLH1 CL E G H42927127OMIM:276300Mismatch repair cancer syndrome 11819
HP:0009733HP:0009718Subependymal giant-cell astrocytoma2TSC1 CL E G H724812362ORPHA:805Tuberous sclerosis complexHP:0040283 - Occasional1090
HP:0009733HP:0009718Subependymal giant-cell astrocytoma2TSC2 CL E G H724912363ORPHA:805Tuberous sclerosis complexHP:0040283 - Occasional2738
HP:0009733HP:0009718Subependymal giant-cell astrocytoma2TSC2 CL E G H724912363OMIM:613254Tuberous sclerosis-22738


Genes (44) :APC APC2 BMPR1A BRCA2 CDKN1A CDKN1B CDKN2A CDKN2B CDKN2C CHEK2 EPCAM ERBB2 FAN1 IDH1 IDH2 IFNG KRAS LRP5 MDM2 MEN1 MLH1 MLH3 MSH2 MSH3 MSH6 NBN NF1 NF2 NSD1 PIK3CA PMS1 PMS2 POT1 RELA RPS20 SEMA4A SETBP1 SETD2 SMO TGFBR2 TP53 TSC1 TSC2 ZFTA

Diseases (36) :OMIM:175100 ORPHA:247806 ORPHA:79665 ORPHA:99818 ORPHA:821 ORPHA:440437 OMIM:613029 ORPHA:652 ORPHA:524 OMIM:155755 OMIM:609265 ORPHA:144 OMIM:137800 ORPHA:163634 ORPHA:805 OMIM:613254 OMIM:259770 OMIM:276300 OMIM:619096 OMIM:617100 ORPHA:480536 OMIM:619097 OMIM:251260 ORPHA:647 ORPHA:97685 ORPHA:363700 OMIM:162200 OMIM:601321 ORPHA:637 OMIM:101000 OMIM:619101 OMIM:616568 ORPHA:251636 ORPHA:798 OMIM:241800 OMIM:191100
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.